HSC Research and Development Limited Partnership
Patent Applications and Registrations
Patent applications and USPTO patent grants for HSC Research and Development Limited Partnership.The latest application filed is for "novel compounds for modulating cell proliferation".
- HSC Research and Development Limited Partnership - CA CA
- HSC Research and Development Limited Partnership - Toronto Ontario CA
- HSC Research and Development Limited Partnership - Suite 5270 555 University Avenue Toronto CA
- HSC Research and Development Limited Partnership - Ontario CA
| Patent | Date |
|---|---|
| Method for treating a brain cancer with ifenprodil Grant 8,058,243 - Tyers , et al. November 15, 2 | 2011-11-15 |
| Methods for detecting the presence of mutant mammalian presenilin protein Grant 7,846,679 - St. George-Hyslop , et al. December 7, 2 | 2010-12-07 |
| Antibody specific for mutant presenilin 2 and method of use thereof Grant 7,838,247 - St. George-Hyslop , et al. November 23, 2 | 2010-11-23 |
| Compounds for modulating cell proliferation Grant 7,598,419 - Roifman , et al. October 6, 2 | 2009-10-06 |
| Verotoxin pharmaceutical compositions and medical treatments therewith Grant 7,560,426 - Lingwood , et al. July 14, 2 | 2009-07-14 |
| Antibody specific for mutant presenilin 1 Grant 7,507,798 - St. George-Hyslop , et al. March 24, 2 | 2009-03-24 |
| Novel Compounds for Modulating Cell Proliferation App 20070243612 - Roifman; Chaim M. ; et al. | 2007-10-18 |
| Verotoxin pharmaceutical compositions and medical treatments therewith Grant 7,208,468 - Lingwood , et al. April 24, 2 | 2007-04-24 |
| Ese genes and proteins Grant 7,118,886 - Egan , et al. October 10, 2 | 2006-10-10 |
| SARA proteins Grant 7,105,636 - Wrana September 12, 2 | 2006-09-12 |
| Verotoxin pharmaceutical compositions and medical treatments therewith Grant 6,835,710 - Lingwood , et al. December 28, 2 | 2004-12-28 |
| Self-aligning peptides modeled on human elastin and other fibrous proteins Grant 6,765,086 - Rothstein , et al. July 20, 2 | 2004-07-20 |
| Products and methods for gaucher disease therapy Grant 6,696,272 - Mahuran , et al. February 24, 2 | 2004-02-24 |
| Hybrid nucleic acid molecules and vectors including .beta.-globin regulatory elements Grant 6,524,851 - Ellis February 25, 2 | 2003-02-25 |
| Episomal expression cassettes for gene therapy Grant 6,372,500 - Hu , et al. April 16, 2 | 2002-04-16 |
| Haemophilus adhesin protein Grant 6,218,147 - Lingwood April 17, 2 | 2001-04-17 |
| Retinal stem cells Grant 6,117,675 - van der Kooy , et al. September 12, 2 | 2000-09-12 |
| Chromosome 13-linked breast cancer susceptibility gene Grant 5,837,492 - Tavtigian , et al. November 17, 1 | 1998-11-17 |
| Soluble TGF-.beta.-binding endoglin polypeptides and homodimers Grant 5,830,847 - Letarte , et al. November 3, 1 | 1998-11-03 |
| Use of endoglin polypeptides for modifying the regulatory activity of TGF-.beta. Grant 5,719,120 - Letarte , et al. February 17, 1 | 1998-02-17 |
| Fanconi Anemia Type C gene Grant 5,681,942 - Buchwald , et al. October 28, 1 | 1997-10-28 |
| Cystic fibrosis transmembrane conductance regulator (CFTR) protein Grant 5,543,399 - Riordan , et al. August 6, 1 | 1996-08-06 |
| Diagnosis for malignant hyperthermia Grant 5,413,907 - Worton , et al. May 9, 1 | 1995-05-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 